KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amneal Pharmaceuticals (AMRX) Shares Outstanding (Weighted Average) (2017 - 2025)

Amneal Pharmaceuticals has reported Shares Outstanding (Weighted Average) over the past 9 years, most recently at $313.4 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $313.4 million for Q4 2025, up 1.42% from a year ago — trailing twelve months through Dec 2025 was $313.4 million (up 1.42% YoY), and the annual figure for FY2025 was $313.4 million, up 1.42%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $313.4 million at Amneal Pharmaceuticals, roughly flat from $314.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for AMRX hit a ceiling of $314.2 million in Q3 2025 and a floor of $148.0 million in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $154.2 million (2023), compared with a mean of $219.4 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 0.57% in 2021 and later soared 102.01% in 2024.
  • Amneal Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $149.3 million in 2021, then rose by 1.11% to $150.9 million in 2022, then grew by 16.69% to $176.1 million in 2023, then soared by 75.42% to $309.0 million in 2024, then rose by 1.42% to $313.4 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $313.4 million (Q4 2025), $314.2 million (Q3 2025), and $312.4 million (Q2 2025) per Business Quant data.